Jun Kuroki

945 total citations
33 papers, 710 citations indexed

About

Jun Kuroki is a scholar working on Molecular Biology, Pharmacology and Immunology. According to data from OpenAlex, Jun Kuroki has authored 33 papers receiving a total of 710 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Pharmacology and 5 papers in Immunology. Recurrent topics in Jun Kuroki's work include Pharmacogenetics and Drug Metabolism (7 papers), Carcinogens and Genotoxicity Assessment (4 papers) and Estrogen and related hormone effects (3 papers). Jun Kuroki is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Carcinogens and Genotoxicity Assessment (4 papers) and Estrogen and related hormone effects (3 papers). Jun Kuroki collaborates with scholars based in Japan and United States. Jun Kuroki's co-authors include Hidetoshi Yoshimura, Akira Miura, Nobuyuki Koga, Makoto Hirokawa, Mitsuyoshi Hirokawa, Takahiro Horiuchi, Yoshiaki Hatano, Kengo Araki, Manabu Kuwada and Nobuyuki Koga and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Brain Research.

In The Last Decade

Jun Kuroki

31 papers receiving 698 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Kuroki Japan 15 228 189 152 105 96 33 710
Prapaporn Kopsombut United States 12 178 0.8× 75 0.4× 97 0.6× 153 1.5× 76 0.8× 18 619
Motohiko Oshima Japan 11 237 1.0× 169 0.9× 116 0.8× 85 0.8× 73 0.8× 28 578
Kay A. Criswell United States 15 202 0.9× 71 0.4× 51 0.3× 87 0.8× 108 1.1× 29 580
Keith Bonham Canada 22 662 2.9× 105 0.6× 84 0.6× 298 2.8× 111 1.2× 39 1.2k
Yoshihiko Kawarada Japan 12 288 1.3× 85 0.4× 47 0.3× 83 0.8× 34 0.4× 34 705
Kimberly Dooley United States 10 775 3.4× 202 1.1× 252 1.7× 20 0.2× 123 1.3× 11 1.3k
Helena Anundi Sweden 19 518 2.3× 109 0.6× 29 0.2× 75 0.7× 94 1.0× 26 953
D. A. Bradbury United Kingdom 18 453 2.0× 161 0.9× 304 2.0× 16 0.2× 64 0.7× 21 836
Ali M. Saboori United States 16 210 0.9× 82 0.4× 106 0.7× 47 0.4× 27 0.3× 23 678
Takeo Kuribayashi Japan 7 427 1.9× 130 0.7× 93 0.6× 25 0.2× 38 0.4× 8 907

Countries citing papers authored by Jun Kuroki

Since Specialization
Citations

This map shows the geographic impact of Jun Kuroki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Kuroki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Kuroki more than expected).

Fields of papers citing papers by Jun Kuroki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Kuroki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Kuroki. The network helps show where Jun Kuroki may publish in the future.

Co-authorship network of co-authors of Jun Kuroki

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Kuroki. A scholar is included among the top collaborators of Jun Kuroki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Kuroki. Jun Kuroki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kobayashi, Takahiro, Yoshihiro Kameoka, Kazuaki Teshima, et al.. (2024). Prognostic impact of peripheral blood WT1 mRNA dynamics in patients with acute myeloid leukemia treated with venetoclax combination therapy. International Journal of Clinical Oncology. 29(4). 481–492. 1 indexed citations
2.
Takahashi, Naoto, Kaichi Nishiwaki, Chiaki Nakaseko, et al.. (2018). Treatment-free remission after two-year consolidation therapy with nilotinib in patients with chronic myeloid leukemia: STAT2 trial in Japan. Haematologica. 103(11). 1835–1842. 59 indexed citations
3.
Watanabe, Akira, Hajime Goto, Hiroo Wada, et al.. (2011). Usefulness of linezolid in the treatment of hospital-acquired pneumonia caused by MRSA: a prospective observational study. Journal of Infection and Chemotherapy. 18(2). 160–168. 4 indexed citations
4.
Okuyama, Shin, et al.. (2008). Successful treatment of post-MRSA infection glomerulonephritis with steroid therapy. Clinical Nephrology. 70(10). 344–347. 24 indexed citations
5.
Kuroki, Jun, Kiyoshi Hasegawa, Ryuji Kato, et al.. (2003). Relationship between the classification of vascular invasion severity and the prognosis of uterine endometrial cancer. International Journal of Gynecological Cancer. 13(1). 47–52. 7 indexed citations
6.
Kawano, Fumiaki, et al.. (2003). [Ruptured aortic arch aneurysm with hemorrhagic cardiac tamponade; report of a case].. PubMed. 56(6). 497–500.
7.
Hirokawa, Makoto, et al.. (2000). Induction of Tissue Factor Production but not the Upregulation of Adhesion Molecule Expression by Ceramide in Human Vascular Endothelial Cells. The Tohoku Journal of Experimental Medicine. 191(3). 167–176. 14 indexed citations
8.
9.
Shimizu, Hiroki, et al.. (1998). Quantitative reverse transcription-PCR-HPLC for nerve growth factor mRNA using a deletion RNA as an internal standard. Biomedical Chromatography. 12(1). 38–42. 5 indexed citations
10.
Yonaga, Masahiro, et al.. (1996). Dopamine D3 agonists disrupt social behavior in rats. Brain Research. 721(1-2). 229–232. 23 indexed citations
11.
12.
Kuroki, Jun, et al.. (1996). Cell-permeable ceramide inhibits the growth of B lymphoma Raji cells lacking TNF-alpha-receptors by inducing G0/G1 arrest but not apoptosis: a new model for dissecting cell-cycle arrest and apoptosis.. PubMed. 10(12). 1950–8. 40 indexed citations
13.
Kuroki, Jun, Makoto Itakura, Shigehisa Hirose, et al.. (1995). Cloning, Characterization, and Tissue Distribution of Porcine SPAI, a Protein with a Transglutaminase Substrate Domain and the WAP Motif. Journal of Biological Chemistry. 270(38). 22428–22433. 13 indexed citations
14.
Hirokawa, Mitsuyoshi, et al.. (1995). Signal transduction by B7/BB1 expressed on activated T lymphocytes: cross-linking of B7/BB1 induces protein tyrosine phosphorylation and synergizes with signalling through T-cell receptor/CD3.. PubMed. 86(2). 155–61. 19 indexed citations
15.
Hagiwara, Hiromi, et al.. (1992). Primary structure of the human elafin precursor preproelafin deduced from the nucleotide sequence of its gene and the presence of unique repetitive sequences in the prosegment. Biochemical and Biophysical Research Communications. 185(1). 240–245. 60 indexed citations
16.
Araki, Kengo, Manabu Kuwada, Osamu Ito, Jun Kuroki, & Shizuko Tachibana. (1990). Four disulfide bonds' allocation of Na+, K+-ATPase inhibitor (SPAI). Biochemical and Biophysical Research Communications. 172(1). 42–46. 12 indexed citations
17.
Araki, Kengo, Jun Kuroki, Osamu Ito, Manabu Kuwada, & Shizuko Tachibana. (1989). Novel peptide inhibitor (SPAI) of Na+, K+-ATPase from porcine intestine. Biochemical and Biophysical Research Communications. 164(1). 496–502. 50 indexed citations
18.
Yoshimura, Hiroaki, Shu Yoshihara, Nobuyuki Koga, et al.. (1985). Inductive effect on hepatic enzymes and toxicity of congeners of PCBs and PCDFs.. Environmental Health Perspectives. 59. 113–119. 5 indexed citations
19.
Yoshimura, Hidetoshi, Shin’ichi Yoshihara, Nobuyuki Koga, et al.. (1985). Inductive Effect on Hepatic Enzymes and Toxicity of Congeners of PCBs and PCDFs. Environmental Health Perspectives. 59. 113–113. 42 indexed citations
20.
Koga, Nobuyuki, et al.. (1983). [Enhancement of reduction activity of 4-nitroquinoline N-oxide in rats pretreated with 3-methylcholanthrene-type PCB].. PubMed. 74(5). 217–21. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Prapaporn Kopsombut Breakdown of academic impact, for papers by Motohiko Oshima Breakdown of academic impact, for papers by Kay A. Criswell Breakdown of academic impact, for papers by Keith Bonham Breakdown of academic impact, for papers by Yoshihiko Kawarada Breakdown of academic impact, for papers by Kimberly Dooley Breakdown of academic impact, for papers by Helena Anundi Breakdown of academic impact, for papers by D. A. Bradbury Breakdown of academic impact, for papers by Ali M. Saboori Breakdown of academic impact, for papers by Takeo Kuribayashi
Rankless by CCL
2026